Foresight Announces First Quarter 2024 Financial Results
28 mai 2024 08h00 HE
|
Foresight Autonomous Holdings Ltd.
NESS ZIONA, Israel, May 28, 2024 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision systems, today...
Fundamental Global Inc. Reports First Quarter 2024 Financial Results
20 mai 2024 08h30 HE
|
Fundamental Global Inc.
Mooresville, NC, May 20, 2024 (GLOBE NEWSWIRE) -- Fundamental Global Inc. (Nasdaq: FGF, FGFPP) (the “Company” or "Fundamental Global"), formerly known as FG Financial Group, Inc. (“FG Financial”),...
Odysight.ai Announces First Quarter 2024 Financial Results and Provides Corporate Update
16 mai 2024 08h30 HE
|
Odysight.ai Inc.
OMER, Israel, May 16, 2024 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (OTCQB: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions,...
Eightco Announces First Quarter 2024 Financial Results
16 mai 2024 08h30 HE
|
Eightco Holdings Inc.
Quarter Driven by Capital Restructuring to Prioritize Financial Stability for Long-Term Revenue Growth. First quarter 2024 net income of $4.9mn versus net loss of $49.9mn for the prior year...
CEA Industries Inc. Reports First Quarter 2024 Results and Provides Update on Strategic Review Process
14 mai 2024 16h50 HE
|
CEA Industries Inc.
Louisville, Colorado, May 14, 2024 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: CEAD, CEADW) (“CEA Industries” or the “Company”), is reporting results for the three months ended March 31, 2024. ...
BioRestorative Therapies Provides First Quarter 2024 Business Update
14 mai 2024 16h10 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., May 14, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based...
IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update
13 mai 2024 08h00 HE
|
Imunon, Inc.
Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on...
GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
13 mai 2024 08h00 HE
|
GRI Bio, Inc.
Interim data readout of Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) expected Q3 2024 and topline data on track for Q4 2024 ...
Research Frontiers Reports First Quarter 2024 Financial Results and Will Host a Conference Call at 5:30p.m. Today
09 mai 2024 16h01 HE
|
Research Frontiers Incorporated
WOODBURY, N.Y., May 09, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its first quarter of 2024. Management will host a conference call today at...
Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
09 mai 2024 16h01 HE
|
Interpace Biosciences, Inc.
●Q1 Revenue of $10.3 million; a 4% increase year-over-year ●Q1 Test volume up 10% year over year to record levels PARSIPPANY, NJ, May 09, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc....